Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism

Mol Genet Metab. 1998 Dec;65(4):264-71. doi: 10.1006/mgme.1998.2758.

Abstract

A 2-year-old female was well until 12 months of age when she was found to be anemic and had dilated cardiomyopathy. Total plasma carnitine was 6 microM and acylcarnitine analysis while receiving carnitine supplement revealed an increase in the four-carbon species. Urine organic acids were normal. In vitro analysis of the mitochondrial pathways for beta oxidation, and leucine, valine, and isoleucine metabolism was performed in fibroblasts using stable isotope-labeled precursors to these pathways followed by acylcarnitine analysis by tandem mass spectrometry. 16-2H3-palmitate was metabolized normally down to the level of butyryl-CoA thus excluding SCAD deficiency. 13C6-leucine and 13C6-isoleucine were also metabolized normally. 13C5-valine incubation revealed a significant increase in 13C4-isobutyrylcarnitine without any incorporation into propionylcarnitine as is observed normally. These same precursors were also evaluated in fibroblasts with proven ETF-QO deficiency in which acyl-CoA dehydrogenase deficiencies in each of these pathways was clearly identified. These results indicate that in the human, there is an isobutyryl-CoA dehydrogenase which exists as a separate enzyme serving only the valine pathway in addition to the 2-methyl branched-chain dehydrogenase which serves both the valine and the isoleucine pathways in both rat and human.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cardiomyopathies
  • Carnitine / analogs & derivatives
  • Carnitine / blood
  • Carnitine / metabolism
  • Carnitine / therapeutic use
  • Child, Preschool
  • Female
  • Fibroblasts / metabolism
  • Humans
  • Infant
  • Male
  • Oxidoreductases / deficiency*
  • Oxidoreductases / metabolism*
  • Oxidoreductases Acting on CH-CH Group Donors*
  • Palmitic Acids / metabolism
  • Palmitic Acids / pharmacokinetics
  • Substrate Specificity
  • Valine / metabolism*

Substances

  • Palmitic Acids
  • isobutyryl-1-carnitine
  • 3-methylbutyrylcarnitine
  • Oxidoreductases
  • Oxidoreductases Acting on CH-CH Group Donors
  • 2-methylacyl-CoA dehydrogenase
  • Valine
  • Carnitine